유럽 폐암 검진 소프트웨어 시장, 제공 모드(클라우드 기반 솔루션, 온프레미스 솔루션 및 웹 기반 솔루션), 제품(폐암 검진 방사선 솔루션, 폐암 검진 환자 관리 소프트웨어, 결절 관리 소프트웨어, 데이터 수집 및 보고, 환자 조정 및 워크플로, 폐 결절 컴퓨터 지원 감지, 병리학 및 암 병기 분류, 통계적 감사 보고, 검진 PAC, 실무 관리 및 감사 로그 추적), 유형(컴퓨터 지원 검진 및 기존 검진), 애플리케이션(비소세포 폐암(NSCLC) 및 소세포 폐암(SCLC)), 플랫폼(독립형 및 통합), 구매 모드(기관 및 개인), 최종 사용자(종양 센터, 병원, 외래 수술 센터 및 기타), 유통 채널(직접 입찰 및 제3자 유통업체) - 업계 동향 및 2029년까지의 예측.
유럽 폐암 검진 소프트웨어 시장 분석 및 규모
폐암 사망률 통제는 의료 시설의 주요 관심사 중 하나입니다. 공공 및 민간 기관은 사망률을 통제하기 위한 검진 프로그램을 시작하기 위한 이니셔티브를 취하고 있습니다. 또한, 회사는 환자 데이터 관리를 용이하게 하고 엄격한 데이터 개인 정보 보호 지침으로 더 나은 치료를 제공하기 위한 고급 소프트웨어를 출시하고 있습니다.
폐암 유병률 증가, 폐암에 대한 사람들의 인식 증가, 정부 이니셔티브 증가, 검진 프로그램 수 증가는 시장 성장을 견인하는 주요 요인 중 일부입니다. 또한, 주요 시장 참여자의 인공지능(AI) 기반 솔루션과 전략적 이니셔티브의 발전은 폐암 검진 소프트웨어 분야에서 기회를 창출하고 있습니다.
그러나 데이터 개인정보 보호 문제와 비숙련 노동력 부족이 예측 기간 동안 시장 성장을 방해할 것으로 예상됩니다.
Data Bridge Market Research는 유럽 폐암 검진 소프트웨어 시장이 2029년까지 27,518.34만 달러에 도달할 것으로 예상하고 있으며, 예측 기간 동안 CAGR은 19.6%입니다. 클라우드 기반 솔루션은 시장에서 가장 큰 제공 모드 세그먼트를 차지합니다. 시장 보고서는 또한 가격 분석, 특허 분석 및 기술 발전에 대한 심층적인 내용을 다룹니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2022년부터 2029년까지 |
|
기준 연도 |
2021 |
|
역사적 연도 |
2020 (2019-2014로 사용자 정의 가능) |
|
양적 단위 |
매출은 천 달러, 가격은 달러로 표시됨 |
|
다루는 세그먼트 |
제공 방식(클라우드 기반 솔루션, 온프레미스 솔루션 및 웹 기반 솔루션), 제품(폐암 검진 방사선 솔루션, 폐암 검진 환자 관리 소프트웨어 , 결절 관리 소프트웨어, 데이터 수집 및 보고, 환자 조정 및 워크플로, 폐 결절 컴퓨터 지원 감지, 병리학 및 암 병기, 통계 감사 보고, 검진 PAC, 진료 관리 및 감사 로그 추적), 유형(컴퓨터 지원 검진 및 기존 검진), 애플리케이션(비소세포 폐암(NSCLC) 및 소세포 폐암(SCLC ), 플랫폼(독립형 및 통합형), 구매 방식(기관 및 개인), 최종 사용자(종양학 센터, 병원, 외래 수술 센터 및 기타), 유통 채널(직접 입찰 및 제3자 유통업체) |
|
적용 국가 |
독일, 영국, 프랑스, 이탈리아, 스페인, 네덜란드, 러시아, 스위스, 터키, 벨기에 및 기타 유럽 국가 |
|
시장 참여자 포함 |
PenRad Technologies Inc., Koninklijke Philips NV, Volpara Health Limited, Thynk Health, Nuance Communications, Inc., Siemens Healthcare GmbH, MyCareWare, Inc., MagView, MeVis Medical Solutions AG, Canon Medical Informatics, Inc., General Electric Company, Epic Systems Corporation, Lungview, Eon, Medtronic, Coreline Soft Co., Ltd., Optellum Ltd, HealthMyne, Oncocyte Corporation, Genesystem, REVEALDX, FUJIFILM Holdings Corporation, F. Hoffmann-La Roche Ltd, Median Technologies, AstraZeneca, Aidence.com |
시장 정의
폐암 검진은 다양한 기술과 소프트웨어를 사용하여 폐암의 단계를 식별하는 것입니다. CT를 사용한 폐암 검진은 폐암 검진에 가장 권장되는 기술입니다. 이 기술의 사용이 증가함에 따라 폐암 검진을 위한 고급 소프트웨어에 대한 필요성이 가속화될 것으로 예상됩니다. 이 소프트웨어는 환자의 폐 검진 프로그램 참여를 관리하는 데 도움이 되며 의료 전문가가 임상의와 환자에게 데이터를 수집, 정리 및 전송할 수 있는 효율적인 방법을 제공합니다. 또한 이 소프트웨어는 위험에 처한 환자를 식별하고 통합된 전자 건강 기록을 통해 데이터 흐름을 자동화합니다.
유럽 폐암 검진 소프트웨어 시장 동향
이 섹션에서는 시장 동인, 기회, 제약 및 과제를 이해하는 것을 다룹니다. 이 모든 내용은 아래에서 자세히 설명합니다.
운전자
- 전 세계적으로 폐암 발병률 증가
폐암은 남성과 여성의 주요 사망 원인입니다. 세계암연구기금(World Cancer Research Fund International)에 따르면 폐암은 전 세계에서 두 번째로 흔한 암입니다. 남성에서 가장 흔한 암이고 여성에서 두 번째로 흔한 암입니다. 2020년에는 22,000건 이상의 새로운 폐암 사례가 발생했습니다. 폐암 사례의 유병률 증가로 인해 조기 진단을 위한 폐암 검진 소프트웨어를 도입해야 할 필요성이 생겨 시장 성장을 촉진하는 요인으로 작용합니다.
- 조기 진단 및 빈번한 검진의 이점에 대한 인식 증가
공공, 비영리, 민간 기관의 폐암에 대한 인식 프로그램이 증가함에 따라 시장 성장이 촉진될 것으로 예상됩니다. 이러한 이니셔티브는 질병을 예방하고, 낙인과 편견을 줄이며, 연구를 촉진하는 것을 목표로 합니다. 폐암에 대한 대중의 인식이 증가했습니다. 다양한 기관에서 많은 인식 프로그램을 실시하기 때문에 사람들은 조기에 진단하면 치료할 수 있는 폐암에 대해 알고 있습니다. 따라서 대중의 인식을 높이는 것이 시장 성장을 촉진하고 있습니다.
- 다양한 질병에 대한 검진 프로그램을 시행하기 위한 정부 이니셔티브가 시작되었습니다.
암의 부담은 전 세계적으로 계속 증가하고 있으며, 건강 시스템, 제품, 가족 및 개인에게 큰 재정적, 정서적, 신체적 스트레스를 줍니다. 강력한 건강 시스템을 갖춘 국가에서는 생존율, 양질의 치료, 인식 증가 및 조기 발견이 용이하기 때문에 많은 유형의 암 생존율이 향상됩니다. 질병 통제 예방 센터, 미국, 부족 및 미국 태평양 섬과 영토는 국가 종합 암 관리 프로그램(NCCCP)을 통해 지역 사회에서 암과 싸우기 위한 동맹을 형성하거나 지원해야 합니다. 이러한 이니셔티브 덕분에 더 많은 청중이 교육을 받고 더 의식적으로 분산되어 글로벌 청중이 추가 예방 조치를 취하고 예방 검진을 실시하여 시장을 홍보합니다.
- 전 세계적으로 증가하는 수의 스크리닝 프로그램
검진은 초기 단계의 암을 발견하는 효과적인 방법입니다. 개발도상국에서 폐암 발병률이 증가하는 추세입니다. 유방암과 자궁경부암 검진에 대한 정기적인 권장 사항이 있지만 폐암의 경우 그렇지 않습니다. 대부분의 국가 또는 기관에서 폐암에 대한 저선량 컴퓨터 단층촬영 (LDCT)의 타당성과 질병 검진을 시작했습니다. 폐암 검진의 증가는 시장 참여자에게 기회를 제공했습니다. 따라서 증가하는 진단율은 시장 성장의 원동력으로 작용합니다.
기회
-
시장 참여자 간의 협력, 합병 및 인수 증가
시장에서 운영되는 회사들은 합병 및 인수, 제품 출시, 계약, 파이프라인 개발, 협업, 시장 확장 등 여러 가지 전략을 채택하여 다양한 차원에서 사업을 확대하고 있습니다. 회사들의 이러한 전략적 결정은 시장에서 운영되는 시장 참여자들에게 상당한 기회를 제공할 것으로 기대됩니다.
제지/도전
- 소프트웨어 가용성과 관련된 문제
개발도상국에서 효과적이고 효율적인 폐암 검진과 폐암 검진 소프트웨어의 가용성과 관련된 특정 문제/장벽이 있습니다. 문제는 시간에 대한 경쟁적 요구, 폐암 검진에 대한 지식, 검진의 효과에 대한 변화하는 태도, 역사적으로 열악한 폐암 치료 결과와 관련된 허무주의, 지방 자치 단체 또는 국가 의료 기기 규제 기관에 대한 제한된 교육 및 요구 사항 승인입니다. 이러한 모든 문제는 제품 출시와 가용성을 지연시킵니다. 또한 폐암 검진 소프트웨어에 대한 수요는 사용 가능한 소프트웨어와 관련된 기술적 문제로 인해 방해를 받아 시장 성장을 제한합니다.
COVID-19 이후 유럽 폐암 검진 소프트웨어 시장에 미치는 영향
COVID-19는 거의 모든 국가가 필수품 부문을 취급하는 곳을 제외한 모든 시설을 폐쇄하기로 결정하면서 다양한 산업에 큰 영향을 미쳤습니다. 정부는 COVID-19의 확산을 막기 위해 시설 폐쇄 및 비필수품 판매, 국제 무역 차단 등 몇 가지 엄격한 조치를 취했습니다. 이 팬데믹 상황에서 운영되고 있던 유일한 사업은 열고 프로세스를 운영할 수 있는 필수 서비스였습니다.
COVID-19는 의료 서비스 제공자가 환자 치료를 제공하는 데 있어 새롭고 생소한 과제를 만들어냈습니다. 폐암 검진과 같은 필수적이지 않지만 중요한 많은 서비스가 직원과 환자의 건강을 보호하기 위해 일시적으로 중단되었습니다. 의료 기관은 COVID-19 기간 동안 치료의 연속성을 보장하고 서비스를 안전하게 계속할 수 있는 시기를 보장하기 위해 일정 조정, 환자 모니터링 및 환자-서비스 커뮤니케이션 후속 조치와 관련하여 전례 없는 과제에 직면했습니다. COVID-19는 폐암 검진 프로그램에 새로운 과제를 만들어냈으며, 많은 경우 검진이 몇 달씩 지연되었고 관리 및 일정 조정 팀에 더 많은 어려움을 초래했습니다. COVID-19 위기는 호흡 지원의 중요성에 대한 새로운 빛을 비추었지만 암 검진에 대한 낙인을 줄이는 데 큰 영향을 미칠 것으로 기대합니다. 미국에는 폐암 검진을 받을 수 있는 자격이 있는 환자가 1,000만 명이 넘지만 그 중 5%도 채 안 되는 사람이 검진 프로그램에 적극적으로 등록되어 있습니다. COVID-19는 시장에 부정적인 영향을 미쳤습니다.
그러나 폐암 검진 소프트웨어 회사는 어려움을 겪고 있으며 상황을 통제하기 위해 지속적으로 다양한 전략적 결정을 내리고 있습니다. 업체는 파트너십, 협업, 합병 및 인수와 같은 전략적 활동에 참여하여 시장에 관련된 기술을 개선합니다. 이를 통해 회사는 시장에 진보적이고 정확한 솔루션을 제공할 것입니다. 또한 산업 전반에 걸쳐 디지털화를 촉진하려는 정부 이니셔티브도 시장 성장으로 이어졌습니다.
최근 개발 사항
- 2022년 7월, GE Healthcare는 최신 제품이자 가장 진보된 초음파인 차세대 Voluson Expert 22를 출시했습니다. GE Healthcare의 수상 경력에 빛나는 Women's Health 포트폴리오에 추가된 이 최신 제품은 그래픽 기반 빔 형성 기술을 활용하여 더 높은 품질의 이미지를 생성하고 이미징 기능에 더 큰 유연성을 제공합니다. 이 제품을 통해 회사는 의료 기관에 대한 제품 및 서비스 제공자 분야에서 입지를 훨씬 강화했습니다.
- 2021년 10월, Thynk Health는 세계에서 가장 진보된 기술로 폐암과 싸우기 위해 Infervision과 파트너십을 맺었다고 발표했습니다. 폐암 검진 및 폐 결절 관리에 대한 기회를 제공합니다. 이 파트너십을 통해 회사는 시장 입지를 강화했습니다.
유럽 폐암 검진 소프트웨어 시장 범위
유럽 폐암 검진 소프트웨어 시장은 제공 방식, 제품, 유형, 애플리케이션, 플랫폼, 구매 방식, 최종 사용자 및 유통 채널을 기준으로 8개의 주요 세그먼트로 세분화됩니다. 이러한 세그먼트 간의 성장은 산업의 빈약한 성장 세그먼트를 분석하고 사용자에게 핵심 시장 애플리케이션을 식별하기 위한 전략적 결정을 내리는 데 도움이 되는 귀중한 시장 개요와 시장 통찰력을 제공하는 데 도움이 됩니다.
배달 방식
- 클라우드 기반 솔루션
- 온프레미스 솔루션
- 웹 기반 솔루션
제공 방식을 기준으로 시장은 클라우드 기반 솔루션, 온프레미스 솔루션, 웹 기반 솔루션으로 구분됩니다.
제품
- 폐암 검진 방사선 솔루션
- 폐암 검진 환자 관리 소프트웨어
- 결절 관리 소프트웨어
- 데이터 수집 및 보고
- 환자 조정 및 워크플로
- 폐 결절 컴퓨터 지원 감지
- 병리학 및 암 병기
- 통계 감사 보고
- PACS 스크리닝
- 실무 관리
- 감사 로그 추적
제품 기준으로 시장은 폐암 검진 방사선 솔루션, 폐암 검진 환자 관리 소프트웨어, 결절 관리 소프트웨어, 데이터 수집 및 보고, 환자 조정 및 워크플로, 폐 결절 컴퓨터 지원 감지, 병리학 및 암 병기 분류, 통계적 감사 보고, 검진 PACS, 진료소 관리 및 감사 로그 추적으로 구분됩니다.
유형
- 컴퓨터 지원 스크리닝
- 전통적인 스크리닝
시장은 유형을 기준으로 컴퓨터 지원 스크리닝과 전통적 스크리닝으로 구분됩니다.
애플리케이션
- 비소세포 폐암(NSCLC)
- 소세포 폐암 (SCLC)
시장은 응용 분야를 기준으로 비소세포 폐암(NSCLC)과 소세포 폐암(SCLC)으로 구분됩니다.
플랫폼
- 독립형
- 통합
플랫폼 기준으로 시장은 독립형과 통합형으로 구분됩니다.
구매 모드
- 기관
- 개인
구매 방식을 기준으로 시장은 개인형과 기관형으로 구분됩니다.
최종 사용자
- 종양학 센터
- 병원
- 외래 수술 센터
- 기타
최종 사용자를 기준으로 시장은 병원, 종양학 센터, 외래 수술 센터 및 기타로 구분됩니다.
유통 채널별
- 직접 입찰
- 제3자 유통업체
유통 채널을 기준으로 시장은 직접 입찰과 제3자 유통업체로 구분됩니다.
유럽 폐암 검진 소프트웨어 시장 지역 분석/통찰력
유럽 폐암 검진 소프트웨어 시장을 분석하고, 위에 언급된 대로 제공 방식, 제품, 유형, 애플리케이션, 플랫폼, 구매 방식, 최종 사용자 및 유통 채널을 기반으로 시장 규모에 대한 통찰력과 추세를 제공합니다.
이 시장 보고서에서 다루는 국가는 독일, 영국, 프랑스, 이탈리아, 스페인, 네덜란드, 러시아, 스위스, 터키, 벨기에 및 기타 유럽 국가입니다. 독일은 폐암이 유럽에서 암 사망의 주요 원인이기 때문에 시장을 지배하고 있으며, 이로 인해 조기 진단을 위한 폐암 검진 소프트웨어를 채택해야 할 필요성이 생깁니다. 게다가 유럽 지역의 우세한 정교한 수준의 의료 시설도 이 지역의 시장이 엄청나게 성장하는 데 기여했습니다.
보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규제의 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 추세 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 유럽 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세의 영향 및 무역 경로가 국가 데이터의 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 유럽 폐암 검진 소프트웨어 시장 점유율 분석
유럽 폐암 검진 소프트웨어 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 유럽의 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 제공된 위의 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.
이 시장에서 활동하는 주요 기업으로는 PenRad Technologies Inc., Koninklijke Philips NV, Volpara Health Limited, Thynk Health, Nuance Communications, Inc., Siemens Healthcare GmBH, MyCareWare, Inc., MagView, MeVis Medical Solutions AG, Canon Medical Informatics, Inc., General Electric Company, Epic Systems Corporation, Lungview, Eon, Medtronic, Coreline Soft, Co., Ltd., Optellum Ltd, HealthMyne, Oncocyte Corporation, Genesystem, REVEALDX, FUJIFILM Holdings Corporation, F. Hoffmann-La Roche Ltd, Median Technologies, AstraZeneca, Aidence.com 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of Europe lung cancer screening software market
- LIMITATION
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- market application coverage grid
- mode of delivery LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insights
- REGULATIONS & REIMBURSEMENT
- IMPACT OF COVID-19 PANDEMIC ON THE MARKET
- Price impact
- Impact on demand
- IMPACT ON SUPPLY CHAIN
- STRATEGIC DECISIONS FOR MANUFACTURERS
- CONCLUSION
- Market Overview
- drivers
- Increasing prevalence of lung cancer cases Europely
- Increasing awareness regarding the benefits of early diagnosis and frequent screening
- Government initiatives undertaken to implement screening programs for various diseases
- Growing number of screening programs across the globe
- Technological advancementS in THE field of healthcare
- RESTRAINTS
- issues related with the availability of software
- Scarcity of technically knowledgeable professionals for cancer diagnosis
- Lack of funding and other resources from various regions for cancer and associated disorders
- OPPORTUNITIES
- Rising collaborations, mergerS & acquisitions among the market players
- Increasing investmentS in healthcare segmentS
- Multiple benefits associated with lung cancer screening software
- CHALLENGES
- High cost of screening software and related services
- Increasing challenges related to development of lung cancer screening software
- Increasing competition in the market
- EUROPE lung cancer screening software MARKET, BY MODE OF DELIVERY
- overview
- Cloud Based Solutions
- On-Premise Solutions
- Web Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT
- overview
- Lung Cancer Screening Radiology Solution
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Lung Cancer Screening Patient Management Software
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Nodule Management Software
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Data Collection and Reporting
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Patient Coordination and Workflow
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Lung Nodule Computer Aided Detection
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Pathology and Cancer Staging
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Statistical Audit Reporting
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Screening PACs
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Practice Management
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Audit Log Tracking
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY type
- overview
- Computer-Assisted Screening
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Traditional Screening
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY application
- overview
- Non-Small Cell Lung Cancer (NSCLC)
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Small Cell Lung Cancer (SCLC)
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY platform
- overview
- Standalone
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Integrated
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY Purchase Mode
- overview
- Institutional
- INDIVIDUAL
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY end user
- overview
- Oncology Centers
- Hospitals
- Ambulatory Surgical Centers
- Others
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY Distribution Channel
- overview
- Direct Tenders
- Third Party Distributor
- Europe lung cancer screening software Market, by Geography
- Europe
- germany
- France
- U.K
- Italy
- SPAIN
- NETHERLANDS
- RUSSIA
- Switzerland
- BELGIUM
- Philippines
- Rest of Europe
- Europe Lung cancer screening software market, COMPANY landscape
- company share analysis: Europe
- Swot analysis
- CompanY profiles
- KONINKLIJKE PHILIPS N.v
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Nuance Communications, Inc.
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Siemens Healthcare GmbH
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Lungview
- COMPANY SNAPSHot
- company share analysis
- Solution Portfolio
- RECENT DEVELOPMENT
- Medtronic
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Thynk health
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- Vital Images (A subsidiary of Canon Group Company)
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- MeVis Medical Solutions AG
- COMPANY SNAPSHot
- Revenue analysis
- product Portfolio
- RECENT DEVELOPMENTS
- HealthMyne
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENTS
- Volpara Solutions Limited
- COMPANY SNAPSHot
- Revenue analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Coreline Soft, Co., Ltd.
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENTS
- EON
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENT
- MyCareWare Inc
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENT
- Optellum Ltd
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- PenRad Technologies Inc.
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENT
- ProVation Medical, Inc.
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENTS
- questionnaire
- related reports
표 목록
TABLE 1 Europe Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 2 Europe Cloud Based Solutions in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand)
TABLE 3 Europe On-Premise Solutions in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand)
TABLE 4 Europe Web Based Solutions in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand)
TABLE 5 Europe Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 6 Europe Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 7 Europe Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 8 Europe Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 9 Europe Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 10 Europe Nodule Management Software in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 11 Europe Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 12 Europe Data Collection and Reporting in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 13 Europe Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 14 Europe Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 15 Europe Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 16 Europe Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 17 Europe Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 18 Europe Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 19 Europe Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 20 Europe Statistical Audit Reporting in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 21 Europe Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 22 Europe Screening PACs in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 23 Europe Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 24 Europe Practice Management in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 25 Europe Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 26 Europe Audit Log Tracking in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 27 Europe Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 28 Europe Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 29 Europe Computer-Assisted Screening in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 30 Europe Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 31 Europe Traditional Screening in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 32 Europe Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 33 Europe Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 34 Europe Non-Small Cell Lung Cancer (NSCLC) in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 35 Europe Non-Small Cell Lung Cancer (NSCLC) in Lung Cancer Screening Software Market, By Product Type, 2018-2027 (USD Thousand)
TABLE 36 Europe Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 37 Europe Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 38 Europe Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 39 Europe Standalone in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 40 Europe Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 41 Europe Integrated in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 42 Europe Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 43 Europe Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 44 Europe Institutional in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 45 Europe Individual in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 46 Europe Lung Cancer Screening Software Market, By end user, 2018-2027 (USD Thousand)
TABLE 47 Europe Oncology Centers in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 48 Europe Hospitals in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 49 Europe Ambulatory Surgical Centers in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 50 Europe Others in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 51 Europe Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 52 Europe Direct Tenders in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 53 Europe Third Party Distributor in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 54 EUROPE LUNG CANCER SCREENING SOFTWARE market, By Country, 2018–2027 (USD thousand)
TABLE 55 Europe Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 56 Europe Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 57 Europe Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 58 Europe Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 59 Europe Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 60 Europe Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 61 Europe Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 62 Europe Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 63 Europe Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 64 Europe Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 65 Europe Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 66 Europe Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 67 Europe Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 68 Europe Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 69 Europe Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 70 Europe Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 71 Europe Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 72 Europe Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 73 Europe Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 74 Europe Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 75 Europe Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 76 Europe Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 77 Europe Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 78 Europe Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 79 Europe Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 80 Germany Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 81 Germany Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 82 Germany Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 83 Germany Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 84 Germany Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 85 Germany Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 86 Germany Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 87 Germany Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 88 Germany Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 89 Germany Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 90 Germany Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 91 Germany Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 92 Germany Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 93 Germany Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 94 Germany Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 95 Germany Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 96 Germany Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 97 Germany Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 98 Germany Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 99 Germany Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 100 Germany Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 101 Germany Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 102 Germany Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 103 Germany Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 104 Germany Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 105 France Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 106 France Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 107 France Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 108 France Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 109 France Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 110 France Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 111 France Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 112 France Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 113 France Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 114 France Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 115 France Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 116 France Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 117 France Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 118 France Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 119 France Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 120 France Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 121 France Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 122 France Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 123 France Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 124 France Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 125 France Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 126 France Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 127 France Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 128 France Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 129 France Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 130 U.K Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 131 U.K Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 132 U.K Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 133 U.K Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 134 U.K Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 135 U.K Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 136 U.K Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 137 U.K Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 138 U.K Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 139 U.K Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 140 U.K Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 141 U.K Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 142 U.K Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 143 U.K Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 144 U.K Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 145 U.K Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 146 U.K Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 147 U.K Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 148 U.K Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 149 U.K Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 150 U.K Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 151 U.K Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 152 U.K Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 153 U.K Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 154 U.K Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 155 Italy Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 156 Italy Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 157 Italy Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 158 Italy Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 159 Italy Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 160 Italy Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 161 Italy Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 162 Italy Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 163 Italy Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 164 Italy Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 165 Italy Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 166 Italy Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 167 Italy Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 168 Italy Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 169 Italy Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 170 Italy Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 171 Italy Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 172 Italy Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 173 Italy Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 174 Italy Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 175 Italy Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 176 Italy Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 177 Italy Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 178 Italy Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 179 Italy Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 180 Spain Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 181 Spain Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 182 Spain Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 183 Spain Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 184 Spain Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 185 Spain Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 186 Spain Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 187 Spain Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 188 Spain Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 189 Spain Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 190 Spain Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 191 Spain Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 192 Spain Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 193 Spain Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 194 Spain Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 195 Spain Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 196 Spain Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 197 Spain Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 198 Spain Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 199 Spain Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 200 Spain Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 201 Spain Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 202 Spain Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 203 Spain Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 204 Spain Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 205 Netherlands Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 206 Netherlands Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 207 Netherlands Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 208 Netherlands Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 209 Netherlands Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 210 Netherlands Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 211 Netherlands Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 212 Netherlands Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 213 Netherlands Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 214 Netherlands Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 215 Netherlands Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 216 Netherlands Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 217 Netherlands Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 218 Netherlands Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 219 Netherlands Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 220 Netherlands Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 221 Netherlands Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 222 Netherlands Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 223 Netherlands Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 224 Netherlands Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 225 Netherlands Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 226 Netherlands Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 227 Netherlands Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 228 Netherlands Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 229 Netherlands Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 230 Russia Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 231 Russia Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 232 Russia Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 233 Russia Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 234 Russia Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 235 Russia Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 236 Russia Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 237 Russia Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 238 Russia Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 239 Russia Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 240 Russia Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 241 Russia Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 242 Russia Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 243 Russia Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 244 Russia Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 245 Russia Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 246 Russia Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 247 Russia Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 248 Russia Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 249 Russia Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 250 Russia Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 251 Russia Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 252 Russia Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 253 Russia Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 254 Russia Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 255 Switzerland Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 256 Switzerland Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 257 Switzerland Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 258 Switzerland Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 259 Switzerland Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 260 Switzerland Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 261 Switzerland Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 262 Switzerland Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 263 Switzerland Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 264 Switzerland Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 265 Switzerland Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 266 Switzerland Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 267 Switzerland Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 268 Switzerland Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 269 Switzerland Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 270 Switzerland Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 271 Switzerland Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 272 Switzerland Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 273 Switzerland Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 274 Switzerland Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 275 Switzerland Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 276 Switzerland Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 277 Switzerland Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 278 Switzerland Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 279 Switzerland Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 280 Belgium Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 281 Belgium Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 282 Belgium Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 283 Belgium Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 284 Belgium Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 285 Belgium Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 286 Belgium Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 287 Belgium Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 288 Belgium Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 289 Belgium Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 290 Belgium Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 291 Belgium Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 292 Belgium Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 293 Belgium Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 294 Belgium Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 295 Belgium Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 296 Belgium Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 297 Belgium Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 298 Belgium Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 299 Belgium Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 300 Belgium Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 301 Belgium Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 302 Belgium Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 303 Belgium Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 304 Belgium Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 305 Turkey Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 306 Turkey Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 307 Turkey Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 308 Turkey Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 309 Turkey Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 310 Turkey Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 311 Turkey Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 312 Turkey Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 313 Turkey Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 314 Turkey Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 315 Turkey Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 316 Turkey Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 317 Turkey Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 318 Turkey Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 319 Turkey Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 320 Turkey Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 321 Turkey Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 322 Turkey Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 323 Turkey Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 324 Turkey Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 325 Turkey Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 326 Turkey Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 327 Turkey Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 328 Turkey Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 329 Turkey Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 330 REST of Asia Pacific Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
그림 목록
FIGURE 1 Europe lung cancer screening software market: segmentation
FIGURE 2 Europe lung cancer screening software market: data triangulation
FIGURE 3 Europe lung cancer screening software market: DROC ANALYSIS
FIGURE 4 Europe lung cancer screening software market: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 Europe lung cancer screening software market: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE Lung cancer screening software MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 7 Europe lung cancer screening software market: INTERVIEW DEMOGRAPHICS
FIGURE 8 Europe lung cancer screening software market: DBMR MARKET POSITION GRID
FIGURE 9 Europe lung cancer screening software market: vendor share analysis
FIGURE 10 Europe lung cancer screening software market: SEGMENTATION
FIGURE 11 RISING lung cancer screening programs and Technological advancement in THE field of healthcare is expected to drive THE Europe lung cancer screening software market IN THE FORECAST PERIOD of 2020 to 2027
FIGURE 12 Cloud based solutions segment is expected to account for the largest share of Europe lung cancer screening software market in 2020 & 2027
FIGURE 13 Drivers, RestrainTs, OPPORTUNITIES & challenges OF Europe Lung Cancer Screening Software market
FIGURE 14 Lung Cancer incidence and mortality rates, 2018
FIGURE 15 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY mode of delivery, 2019
FIGURE 16 Europe Lung cancer screening software market: BY Mode of Delivery, 2019-2027 (USD Thousand)
FIGURE 17 Europe Lung cancer screening software market: BY Mode of Delivery, CAGR (2020-2027)
FIGURE 18 Europe Lung cancer screening software market: BY Mode of Delivery, LIFELINE CURVE
FIGURE 19 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY product, 2019
FIGURE 20 Europe Lung cancer screening software market: BY product, 2019-2027 (USD Thousand)
FIGURE 21 Europe Lung cancer screening software market: BY product, CAGR (2020-2027)
FIGURE 22 Europe Lung cancer screening software market: BY product, LIFELINE CURVE
FIGURE 23 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY type, 2019
FIGURE 24 Europe Lung cancer screening software market: BY type, 2019-2027 (USD Thousand)
FIGURE 25 Europe Lung cancer screening software market: BY type, CAGR (2020-2027)
FIGURE 26 Europe Lung cancer screening software market: BY type, LIFELINE CURVE
FIGURE 27 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY application, 2019
FIGURE 28 Europe Lung cancer screening software market: BY application, 2019-2027 (USD Thousand)
FIGURE 29 Europe Lung cancer screening software market: BY application, CAGR (2020-2027)
FIGURE 30 Europe Lung cancer screening software market: BY application, LIFELINE CURVE
FIGURE 31 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY platform, 2019
FIGURE 32 Europe Lung cancer screening software market: BY platform, 2019-2027 (USD Thousand)
FIGURE 33 Europe Lung cancer screening software market: BY platform, CAGR (2020-2027)
FIGURE 34 Europe Lung cancer screening software market: BY platform, LIFELINE CURVE
FIGURE 35 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY Purchase Mode, 2019
FIGURE 36 Europe Lung cancer screening software market: BY Purchase Mode, 2019-2027 (USD Thousand)
FIGURE 37 Europe Lung cancer screening software market: BY Purchase Mode, CAGR (2020-2027)
FIGURE 38 Europe Lung cancer screening software market: BY Purchase Mode, LIFELINE CURVE
FIGURE 39 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY end user, 2019
FIGURE 40 Europe Lung cancer screening software market: BY end user, 2019-2027 (USD Thousand)
FIGURE 41 Europe Lung cancer screening software market: BY end user, CAGR (2020-2027)
FIGURE 42 Europe Lung cancer screening software market: BY end user, LIFELINE CURVE
FIGURE 43 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY Distribution Channel, 2019
FIGURE 44 Europe Lung cancer screening software market: BY distribution channel, 2019-2027 (USD Thousand)
FIGURE 45 Europe Lung cancer screening software market: BY distribution channel, CAGR (2020-2027)
FIGURE 46 Europe Lung cancer screening software market: BY distribution channel, LIFELINE CURVE
FIGURE 47 EUROPE Lung cancer screening software MARKET: SNAPSHOT (2019)
FIGURE 48 EUROPE Lung cancer screening software MARKET: by COUNTRY (2020)
FIGURE 49 EUROPE Lung cancer screening software MARKET: by COUNTRY (2019 & 2027)
FIGURE 50 EUROPE Lung cancer screening software MARKET: by COUNTRY (2019 & 2027)
FIGURE 51 EUROPE Lung cancer screening software MARKET: by TYPE (2020-2027)
FIGURE 52 Europe Lung cancer screening software market: company share 2019 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
